Current status of studies with adriamycin (NSC-123127).
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002648:Child; D006224:Cricetinae; D003630:Daunorubicin / Q000494:pharmacology; D004285:Dogs; D004317:Doxorubicin / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006321:Heart / Q000187:drug effects; D006801:Humans; D008099:Liver / Q000378:metabolism; D051379:Mice; D008854:Microscopy, Electron; D011817:Rabbits; D051381:Rats
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin; D003630:Daunorubicin